why choose us

First received: October 14, 2022

Clinical Trial: Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: A Multicentre, Open-label, Single-arm Study to Investigate the Efficacy and Safety of Triptorelin Pamoate 22.5 mg 6-month Formulation in Chinese Patients With Locally Advanced or Metastatic Prostate C

Brief Summary: The main aim of this study is to assess the effectiveness and safety of the 6-month formulation of triptorelin pamoate in Chinese participants with locally advanced or metastatic cancer of the prostate.Participants will receive 1 injection of triptorelin pamoate 6-month formulation.

Read more